In vitro and in vivo effects of natural putative secretagogues of Glucagon-like peptide-1 (GLP-1)

36Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66-386%; P<0.05-0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes. © Rafferty et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria.

Cite

CITATION STYLE

APA

Rafferty, E. P., Wylie, A. R., Elliott, C. T., Chevallier, O. P., Grieve, D. J., & Green, B. D. (2011). In vitro and in vivo effects of natural putative secretagogues of Glucagon-like peptide-1 (GLP-1). Scientia Pharmaceutica, 79(3), 615–621. https://doi.org/10.3797/scipharm.1104-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free